A day after Eli Lilly’s obesity and weight-loss therapies were removed from the regulator’s database, Novo Nordisk also made strides in boosting the supply of all but one of semaglutide’s shortages.
Tag Archive for: weight management
As Eli Lilly’s weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk’s Wegovy, some doctors say their guiding principle for writing prescriptions is simple: which drug can my patients actually get at the pharmacy?
Revita is an outpatient endoscopic procedure that involves resurfacing the mucosal lining of the duodenum, the first part of the small intestine just after the stomach, which is responsible for breaking down food into absorbable nutrients.
Multiple doses of Eli Lilly’s top-selling diabetes medication Mounjaro (tirzepatide) will be in short supply through April 2024, according to the FDA’s database for drug shortages and discontinuations.
Following its label expansion earlier this month, Medicare on Thursday said it will now cover the use of Novo Nordisk’s Wegovy in patients with overweight or obesity who have preexisting cardiovascular disease.
The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly’s (LLY.N) highly-effective Zepbound, but Amgen is taking a unique approach.
To combat the growing obesity crisis in the United States, four lawmakers reintroduced the Treat and Reduce Obesity Act, which would expand Medicare coverage to include weight management medications.
Danish drugmaker Novo Nordisk has been suspended from the Association of the British Pharmaceutical Industry for two years over what the ABPI on Thursday described as “serious breaches” of its code of practice.
The American Academy of Pediatrics (AAP) on Monday recommended use of weight-loss drugs in children ages 12 years or older for treatment of obesity, which impacts about 14.4 million kids and adolescents in the United States and can lead to serious health complications.
The manufacturer of the oral weight loss medication brand Contrave has launched the brand’s new campaign, which aims to demonstrate the unique challenges individuals who are overweight or suffering from obesity face and emphasizes the need for a personalized approach to weight loss to achieve long-term success.